MARKET

SCTL

SCTL

SOCIETAL CDMO INC
NASDAQ
0.5220
-0.0179
-3.32%
After Hours: 0.5118 -0.0102 -1.95% 17:31 02/27 EST
OPEN
0.5200
PREV CLOSE
0.5399
HIGH
0.5467
LOW
0.4900
VOLUME
94.50K
TURNOVER
0
52 WEEK HIGH
1.510
52 WEEK LOW
0.2600
MARKET CAP
54.70M
P/E (TTM)
-1.8271
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at SCTL last week (0219-0223)?
Weekly Report · 1d ago
Weekly Report: what happened at SCTL last week (0212-0216)?
Weekly Report · 02/19 10:04
Weekly Report: what happened at SCTL last week (0205-0209)?
Weekly Report · 02/12 09:59
Booming weight-loss drug market to lift “pick-and-shovel” plays: Jefferies
Jefferies says Novo Nordisk’s parent agreed to acquire U.S. Contract manufacturer Catalent to support its obesity drug business. The weight-loss drug market is expected to be a $3.8B opportunity for “pick-and-shovel” plays in the obesity drug market. Jefferies highlighted the relatively unknown beneficiaries of a booming weight loss drug market last week.
Seeking Alpha · 02/11 17:00
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Societal CDMO (NASDAQ:SCTL) shares moved upwards by 23.4% to $0.57 during Wednesday's pre-market session. Elicio Therapeutics and PepGen also moved upwards. Apollomics shares rose by 19.86% during the session. Losers CytoMed Therapeutic and GRI Bio stock declined by 16.9%.
Benzinga · 02/07 13:06
Weekly Report: what happened at SCTL last week (0129-0202)?
Weekly Report · 02/05 10:03
Analysts Offer Insights on Healthcare Companies: Fennec Pharmaceuticals (FENC) and Societal CDMO (SCTL)
2 analysts have maintained Buy ratings on Fennec Pharmaceuticals and Societal CDMO. Craig-Hallum analyst Chase Knickerbocker maintained a Buy rating on the Healthcare sector stock today. The company’s shares closed at $9.99 on Tuesday. The analyst consensus on SocietalCDMO is a Buy.
TipRanks · 02/01 14:10
Weekly Report: what happened at SCTL last week (0122-0126)?
Weekly Report · 01/29 09:58
More
About SCTL
Societal CDMO, Inc. is a bi-coastal contract development and manufacturing organization (CDMO). The Company is engaged in spanning pre-investigational new drug development to commercial manufacturing and packaging for a range of therapeutic dosage forms with a primary focus on the area of small molecules. It is involved in CDMO providing therapeutic development, end-to-end regulatory support, clinical and commercial manufacturing, aseptic fill/finish, lyophilization, packaging and logistics services to the global pharmaceutical market. The Company’s products include Ritalin LA, Focalin XR, Verelan PM, Verelan SR, Verapamil PM, Verapamil SR, Donnatal liquids and tablets and Scot-Tussin cough and cold liquids. Its manufacturing and development capabilities include product development from formulation through clinical trial and commercial manufacturing, and specialized capabilities for solid oral dosage forms and facilities to handle highly potent compounds and controlled substances.

Webull offers Societal CDMO Inc stock information, including NASDAQ: SCTL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SCTL stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SCTL stock methods without spending real money on the virtual paper trading platform.